参考文献/References:
[1]邱金花,孟令丹,马良,等.乌灵胶囊联合阿立哌唑治疗儿童慢性抽动障碍的效果分析[J].中国妇幼保健,2016,31(24):5398-5400.
[2]Fleischhacker WW,Sanchez R,Perry PP,et al.Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study[J].British Journal of Psychiatry,2018,205(2):135-144.
[3]吴传军,陈燕惠.经颅微电流刺激与阿立哌唑治疗儿童抽动障碍的对照研究[J].中国儿童保健杂志,2016,24(6):576-578.
[4]Potkin S,Schmidt SN,Salzman P,et al.Effect sizes of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia:a post-hoc analysis of Qualify[J].European Neuropsychopharmacology,2016,26(2):S564-S565.
[5]蔡晓楠,何学莲,吴革菲,等.阿立哌唑治疗儿童Tourette综合征的疗效及安全性分析[J].中华实用儿科临床杂志,2016,31(18):1426-1431.
[6]Ghanizadeh A.Twice-weekly aripiprazole for treating children and adolescents with tic disorder, a randomized controlled clinical trial[J].Annals of General Psychiatry,2016,15(1):21.
[7]姜琳.托莫西汀和阿立哌唑治疗儿童注意缺陷多动障碍的疗效比较[J].现代药物与临床,2017,32(2):245-248.
[8]Wang S,Wei YZ,Yang JH,et al.The efficacy and safety of aripiprazole for tic disorders in children and adolescents:A systematic review and meta-analysis[J].Psychiatry Research,2017(254):24-32.
[9]朱彦丽,王立文,彭晓音,等.不同剂量阿立哌唑治疗儿童Tourette综合征的长期疗效及安全性研究[J].北京医学,2017,39(7):674-677.
[10]Chandradasa M,Champika L.The use of aripiprazole for tic disorders in children and adolescents and implications for resource limited settings in the developing world[J].Psychiatry Research,2017,29(263):298.
[11]姜淑珍,闫琨,傅勇辉,等.阿立哌唑治疗儿童青少年精神分裂症的血药浓度与临床疗效分析[J].国际精神病学杂志,2017(6):987-990.
[12]Pozzi M,Pisano S,Bertella S,et al.Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison[J].Journal of Clinical Psychiatry,2016,77(12):e1601.
[13]赵欣,吴敏,张欣,等.抽动障碍药物治疗现状分析[J].国际精神病学杂志,2016(4):617-619.
[14]Brasas FDLT,Domínguez AD,Hernández NE,et al.Hoarding disorder and obsessive-compulsive disorder[J].European Psychiatry,2016(33):S350.
[15]纪小艺,吴敏.抽动障碍患儿治疗前后多巴胺D2受体与转运体mRNA的表达[J].中国当代儿科杂志,2016,18(4):297-300.
[16]何玉琼,刘剑波,孟甜甜,等.小儿智力糖浆治疗儿童注意缺陷多动障碍疗效和安全性的多中心临床观察[J].中华实用儿科临床杂志,2017,32(17):1331-1334.
相似文献/References:
[1]廖鸿钊,钟建辉.氯氮平联合阿立哌唑、利培酮治疗难治性精神分裂症的疗效及对患者糖脂代谢水平的影响[J].医学信息,2022,35(09):141.[doi:10.3969/j.issn.1006-1959.2022.09.035]
LIAO Hong-zhao,ZHONG Jian-hui.Clinical Efficacy of Clozapine Combined with Aripiprazole and Risperidone in the Treatment of Treatment Resistant Sehizophrenia and its Effect on Glucose and Lipid Metabolism[J].Journal of Medical Information,2022,35(20):141.[doi:10.3969/j.issn.1006-1959.2022.09.035]
[2]吴金丽.阿立哌唑的临床应用[J].医学信息,2018,31(14):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
WU Jin-li.Clinical Application of Aripiprazole[J].Journal of Medical Information,2018,31(20):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
[3]孙来顺.精神分裂症的药物治疗[J].医学信息,2021,34(21):42.[doi:10.3969/j.issn.1006-1959.2021.21.010]
SUN Lai-shun.Drug Treatment of Schizophrenia[J].Journal of Medical Information,2021,34(20):42.[doi:10.3969/j.issn.1006-1959.2021.21.010]
[4]郝剑辉,崔红兵,郭娅慧.阿立哌唑合并氯氮平治疗难治性精神分裂症的疗效[J].医学信息,2020,33(03):144.[doi:10.3969/j.issn.1006-1959.2020.03.046]
HAO Jian-hui,CUI Hong-bing,GUO Ya-hui.Effect of Aripiprazole Combined with Clozapine in the Treatment of Refractory Schizophrenia[J].Journal of Medical Information,2020,33(20):144.[doi:10.3969/j.issn.1006-1959.2020.03.046]
[5]黄美英,符 奇.奥氮平与阿立哌唑治疗首发精神分裂症的效果及其对患者认知功能的影响[J].医学信息,2020,33(21):149.[doi:10.3969/j.issn.1006-1959.2020.21.046]
HUANG Mei-ying,FU Qi.The Effect of Olanzapine and Aripiprazole in the Treatment of First-episode Schizophrenia and Its Influence on Patients’ Cognitive Function[J].Journal of Medical Information,2020,33(20):149.[doi:10.3969/j.issn.1006-1959.2020.21.046]
[6]李书元.氟西汀联合阿立哌唑治疗抑郁症的临床效果及对患者睡眠质量的影响[J].医学信息,2024,37(02):124.[doi:10.3969/j.issn.1006-1959.2024.02.024]
LI Shu-yuan.Clinical Effect of Fluoxetine Combined with Aripiprazole in the Treatment of Depression and its Effect on Sleep Quality[J].Journal of Medical Information,2024,37(20):124.[doi:10.3969/j.issn.1006-1959.2024.02.024]